Congress leaders raise concern over grant of permission for restricted use of COVID-19 vaccine

Credit: Hindu- Published on January 3, 2021
India’s drugs regulator DCGI on January 3 approved Oxford’s COVID-19 vaccine Covishield and Bharat Biotech’s Covaxin for restricted emergency use

Video credit: Oneindia
Published on January 3, 2021 -  01:22
Congress raises concerns over approval given to Bharat Biotech's Covaxin vaccine| Oneindia News
Hours after India's drug regulator approved indigenously developed 'Covaxin' of Bharat Biotech, Congress leaders raised concern over the grant of permission for the restricted use of Covaxin without its phase 3 trials. Congress leaders asked the government to explain why mandatory protocols and verification of data has been dispensed with and warned the approval was premature'. Congress leader Anand Sharma said the issue of granting authorisation to Bharat Biotech's vaccine needs to be taken carefully. Congress MP Shashi Tharoor and Jairam ramesh also expressed apprehensions over approval to Covaxin, saying it has not yet had phase 3 trials. #Covaxin #Covidshield #Covid-19

You are here

Related videos from verified sources

India at UN: COVID vaccine will be accessible for the benefit of entire humanity 05:26
Credit: ANI - Published on January 30, 2021 

In-depth: New data on Johnson & Johnson COVID-19 vaccine 03:24
Credit: ABC 10 News | San Diego - Published on January 30, 2021 

State leaders hope 2nd dose shots ease long-term care employees’ vaccine reluctancy over the 1st shot 04:08
Credit: WPTV News | West Palm Beach - Published on January 30, 2021 

You might like